SCHEMBL5794329

SCHEMBL5794329

C=COC(=O)Cc1cccs1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 4/20 0.49
▸ MEN1 O00255 3/20 0.49
▸ KMT2A Q03164 3/20 0.49
▸ L3MBTL1 Q9Y468 6/20 0.48
▸ POLB P06746 6/20 0.48
▸ ALDH1A1 P00352 5/20 0.48
▸ MAPT P10636 2/20 0.48
▸ TDP1 Q9NUW8 1/20 0.48
▸ HPGD P15428 3/20 0.47
▸ CYP2C19 P33261 2/20 0.47
▸ RAB9A P51151 4/20 0.46
▸ SMN1; SMN2 Q16637 4/20 0.46
▸ CYP1A2 P05177 1/20 0.46
▸ CYP3A4 P08684 1/20 0.46
▸ CYP2C9 P11712 1/20 0.46
▸ CASP3 P42574 1/20 0.44
▸ SENP8 Q96LD8 1/20 0.44
▸ SENP7 Q9BQF6 1/20 0.44
▸ SENP6 Q9GZR1 1/20 0.44
▸ GAA P10253 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11309756 0.88 NPC1 (0.50) NPC1MEN1KMT2AL3MBTL1POLB
SCHEMBL6241173 0.83 L3MBTL1 (0.52) NPC1MEN1KMT2AL3MBTL1POLB
SCHEMBL8903536 0.83 L3MBTL1 (0.49) NPC1MEN1KMT2AL3MBTL1POLB
SCHEMBL6960073 0.80 NPC1 (0.53) NPC1MEN1KMT2AL3MBTL1POLB
SCHEMBL6536540 0.80 L3MBTL1 (0.49) NPC1MEN1KMT2AL3MBTL1POLB
SCHEMBL11217076 0.80 NPC1 (0.55) NPC1MEN1KMT2AL3MBTL1POLB
SCHEMBL27773069 0.78 NPC1 (0.54) NPC1MEN1KMT2AL3MBTL1POLB
SCHEMBL6536542 0.77 CYP2C19 (0.43) NPC1MEN1KMT2AL3MBTL1POLB
SCHEMBL236205 0.77 HPGD (0.56) NPC1MEN1KMT2AL3MBTL1POLB
SCHEMBL11344695 0.77 HPGD (0.51) MEN1KMT2APOLBALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2003057896-A1 METHODS FOR PREPARING ANTHRACYCLINONE DERIVATIVES AND ANTHRACYCLINONE DERIVATIVES PER SE ALBANY MOLECULAR RESEARCH, INC. (US) 2003-07-17 — — WO claimed
WO-2003057687-A1 METHODS FOR PREPARING DOXORUBICIN DERIVATIVES ALBANY MOLECULAR RESEARCH, INC. (US) 2003-07-17 — — WO claimed
WO-2006012277-A2 BIOCATALYTIC PROCESS FOR PREPARING ENANTIOMERICALLY ENRICHED PRAMIPEXOLE AMR TECHNOLOGY, INC. (US) 2006-02-02 — — WO disclosed
WO-2003057687-A1 METHODS FOR PREPARING DOXORUBICIN DERIVATIVES ALBANY MOLECULAR RESEARCH, INC. (US) 2003-07-17 — — WO disclosed
WO-2003057896-A1 METHODS FOR PREPARING ANTHRACYCLINONE DERIVATIVES AND ANTHRACYCLINONE DERIVATIVES PER SE ALBANY MOLECULAR RESEARCH, INC. (US) 2003-07-17 — — WO disclosed
Send feedback